What is Retractable Technologies?
Retractable Technologies is a manufacturer and marketer of innovative safety medical products, including the VanishPoint® and Patient Safe® lines, alongside the EasyPoint® needle. Their core product, the VanishPoint® syringe, is engineered to retract the needle directly from the patient post-use, thereby mitigating the risk of needlestick injuries and product reuse. The Patient Safe® syringes are specifically designed to combat bloodstream infections linked to catheter hub contamination. Furthermore, the EasyPoint® needle offers a retractable solution compatible with various syringe types for injections, fluid aspiration, and blood collection, underscoring the company's commitment to enhancing patient safety and healthcare worker well-being through advanced medical device technology.
How much funding has Retractable Technologies raised?
Retractable Technologies has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Retractable Technologies
PPP
Public-Private Partnership
What's next for Retractable Technologies?
The recent major strategic investment positions Retractable Technologies for accelerated expansion and further innovation in the safety medical device sector. With a focus on preventing healthcare-associated infections and injuries, the company is poised to capitalize on increasing global demand for advanced safety solutions. Future endeavors will likely involve scaling production, expanding market reach, and potentially developing next-generation products that further enhance patient and clinician safety. This strategic financing will be instrumental in solidifying Retractable Technologies' market leadership and driving its mission to create a safer healthcare environment.
See full Retractable Technologies company page
